Race Shown to Affect Severity of Lupus Disease

September 8, 2009 By Glenda Fauntleroy

In patients with systemic lupus erythematosus, their race can affect how severe the disease will become, according to a new study.

Systemic erythematosus (SLE) is the most common form of lupus — a that can affect various parts of the body, especially the kidneys, joints, blood and nervous system.

The study, which appears in the summer issue of the journal Ethnicity & Disease, looked at how some factors might influence the severity of SLE in different patients, including race, age, sex, ethnicity and the method of payment for care.

The researchers used hospital discharge data from the Dallas-Fort Worth Hospital Council for nearly 15,000 patients hospitalized with SLE between 1999 and 2005. Ninety percent of these were adult women and patients were white, African-American or Hispanic.

The study showed that women were three times more likely to have SLE than men were, and that patients with SLE were more than five times as likely to have multiple autoimmune diseases. Race and ethnicity were indeed a factor in SLE, as the results showed that white patients were only about half as likely as others to have SLE.

“Ethnic minority populations have a higher incidence of severe SLE for several reasons, such as a lower socioeconomic status, barriers to adequate health care and genetic predisposition,” said lead author Katie Crosslin, from Children’s Medical Center in Dallas.

For patients with SLE, comorbidities — additional diseases — make their condition more severe and affect their treatment regimen. Crosslin and her colleague found that African-American and Hispanic patients were two times higher risk of having nephritis, failure and pericarditis (swelling of the heart’s lining) than whites were.

Hispanic women suffer the most severe cases of SLE and comorbidities — they were 61 percent more likely to have nephritis and 55 percent more likely to have diabetes, for example.

“Rheumatologists are aware of the differences in severity and outcome of lupus among patients of different racial groups,” said Graciela Alarcón, M.D., a professor of epidemiology at the University of Alabama at Birmingham.

However, she said that these differences are not common knowledge among “general practitioners who are the ones more likely to encounter patients at disease onset when disease manifestations may not be so obvious.”
Alarcón added that delays in referring patients to a specialist for proper diagnosis might cause harmful setbacks in adequate treatment.

More information: Crosslin KL, Wiginton KL. The impact of race and ethnicity on disease severity in . & Disease 19(3), 2009.

Provided by Health Behavior News Service (news : web)

Related Stories

Recommended for you

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

Portable 3-D scanner assesses patients with elephantiasis

October 17, 2017
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis. Health-care ...

New tools to combat kidney fibrosis

October 16, 2017
Interstitial fibrosis – excessive tissue scarring – contributes to chronic kidney disease, which is increasing in prevalence in the United States.

How hepatitis C hides in the body

October 13, 2017
The Hepatitis C (HCV) virus is a sly enemy to have in one's body. Not only does it manage to make itself invisible to the immune system by breaking down communication between the immune cells, it also builds secret virus ...

Largest study yet of malaria in Africa shows historical rates of infection

October 12, 2017
(Medical Xpress)—A team of researchers with members from the Kenya Medical Research Institute, the University of Oxford and the University of KwaZulu-Natal has conducted the largest-ever study of the history of malaria ...

Promising new target for treatment of psoriasis is safe, study shows

October 11, 2017
A protein known to play a significant role in the development of psoriasis can be prevented from functioning without posing a risk to patients, scientists at King's College London have found.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

PPihkala
not rated yet Sep 08, 2009
I wonder what is the relation between vitamin D status and lupus, since it's becoming accepted that lots of people do not have proper levels of vitamin D in their blood. And darker skin makes this more probably because it blocks more effectively the sun generated portion of vitamin D.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.